November 25, 2015
Article
Editor's Page
When tyrosine kinase inhibitors benefit patients with CML, can treatment ever be stopped? Experts are looking for an answer.
October 16, 2015
Article
Voices
I don't sign the hospitality guest book. I'm a ghost floating through the corridors. I don't want to make an impact here; don't want to call Roswell Park Cancer Institute home. But when a stranger offers comfort, I'm filled with hope.
October 16, 2015
Article
Editor's Page
Immunotherapy – it's the buzzword of the moment. It would be difficult to imagine an area of the field generating more excitement and hope than immuno-oncology is sparking right now.
October 16, 2015
Article
From the Chairman
September was Blood Cancer Awareness Month, a time to offer support to patients and spread awareness about these diseases both inside and outside the cancer community.
October 16, 2015
Article
Side Note
Investigational treatments for myeloproliferative neoplasms promise more than symptom palliation.
October 15, 2015
Article
Features
By donating stem cells through Be The Match, healthy adults can save the lives of people with blood cancers.
October 14, 2015
Article
Features
For adults with acute leukemia, CAR T cell immunotherapies, targeted drugs and pediatric chemotherapy regimens are improving outcomes.
October 13, 2015
Article
Side Note
Two types of effective treatments for non-Hodgkin lymphoma are cell signaling inhibitors and monoclonal antibodies.
October 08, 2015
Article
Features
After stem cell transplants for blood cancers, patients -- with help from their caregivers -- must be careful to avoid infections.
October 07, 2015
Article
Features
With new treatments transforming multiple myeloma into a chronic condition and additional therapies on the horizon, some experts believe a cure is within view.
October 05, 2015
Article
Features
Researchers say breakthrough blood cancer therapies are worth the high cost. Other experts disagree.